参考文献/References:
[1] Guariguata L. By the numbers:new estimates from the IDF diabetes atlas update for 2012[J]. Diabetes Res Clin Pract,2012,98(3):524-525.
[2] Pappachan JM, Varghese GI, Sriraman R, et al. Diabetic cardiomypathy:pathophysiology, diagnostic evaluation and management[J]. World J Diabetes,2013,4(5):177-189.
[3] Chavali V, Tyagi SC, Mishra PK. Predictors and prevention of diabetic cardiomyopathy[J]. Diabetes Metab Syndr Obes,2013,2013(6):151-160.
[4] Duan J, Wei G, Cui J, et al. Aralia taibiensis protects cardiac myocytes against high glucose-induced oxidative stress and apoptosis[J]. Am J Chin Med,2015,43(6):1159-1175.
[5] Winhofer Y, Krssák M, Jankovic D, et al. Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects[J]. Diabetes,2012,61(5):1210-1216.
[6] Calligaris SD, Lecanda M, Solis F, et al. Mice long-term high-fat diet feeding recapitulates human cardiovascular alteration:an animal model to study the early phases of diabetic[J]. PLoS One,2013,8(4):e60931.
[7] van de Weijer T,Schrauwen-Hinderling VB,Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy[J]. Cardiovasc Res,2011,92(1):10-18.
[8] van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity[J]. Physiol Behav,2008,94(2):231-241.
[9] Srivastava A, Shinn AS, Lee PJ, et al.MKK3 mediates inflammatory response through modulation of mitochondrial function[J].Free Radic Biol Med,2015,83(15):139-148.
[10] Risco A, del Fresno C, Mambol A, et al. p38γ and p38δ kinases regulate the Toll-like receptor 4(TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation[J]. Proc Natl Acad Sci USA,2012,109(28):11200-11205.
[11] Guleria RS, Choudhary R, Tanaka T, et al. Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis:role of the renin-angiotensin system[J]. J Cell Physiol,2011,226(5):1292-1307.
[12] Kumar R, Yong QC, Thomas CM, et al. Intracardiac intracellular angiotensin system in diabetes[J]. Am J Physiol Regul Integr Comp Physiol,2012,302(5):R510-R517.
[13] Kurdi M, Booz GW. New take on the role of angiotensin Ⅱ in cardiac hypertrophy and fibrosis[J]. Hypertension,2011,57(6):1034-1038.
[14] Thomas CM, Yong QC, Seqqat R, et al. Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model:comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor[J]. Clin Sci,2013,124(8):529-541.
[15] Hohensinner PJ, Niessner A, Huber K, et al. Inflammation and cardiac outcome[J]. Curr Opin Infect Dis,2011,24(3):259-264.
[16] Tanaka K, Essick EE, Doros G, et al. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis[J]. J Am Heart Assoc,2013,2(2):e005868.
[17] Wauman J, Tavemier J. Leptin receptor signaling:pathways to leptin resistance[J].Front Biosci(Landmark Ed),2011,17(16):2771-2793.
[18] Vasselli JR. The role of dietary components in leptin resistance[J]. Adv Nutr,2012,3(5):736-738.
[19] Erickson JR, Pereira L, Wang L, et al. Diabetic hyperglycemia activates CaMKⅡ and arrhythmias by O-linked glycosylation[J]. Nature,2013,502(7471):372-376.
[20] Dhalla NS, Takeda N, Rodriguez-Leyya D, et al. Mechanisms of subcellular remodeling in heart falure due to diabetes[J].Heart Fail Rev,2014,19(1):87-99.
[21] Kumar S, Kain V, Sitasawad SL. High glucose-induced Ca2+ overload and oxidative stress contribute to apoptosis of cardiac cells through mitochondrial dependent and independent pathways[J]. Biochim Biophys Acta,2012,1820(7):907-920.
[22] Liu C, Wang L, He K. Diabetic cardiomyopathy and autophagy[J]. Zhonghua Bing Li Xue Za Zhi,2015,44(2):146-149.
[23] Kubli DA, Gustafsson AB. Unbreak my heart:targeting mitochondrial autophagy in diabetic cardiomyopathy[J]. Antioxid Redox Signal,2015,22(17):1527-1544.
[24] Bariow AD, Thomas DC. Autophagy in diabetes:β-cell dysfunction, insulin resistance, and complications[J]. DNA Cell Biol,2015,34(4):252-260.
[25] Pappachan JM, Varughese GI, Sriraman R, et al. Diabetic cardiomyopathy: pathophysiology, diagnostic evaluation and management[J]. World J Diabetes,2013,4(5):177-189.
[26] Adameova A, Dhalla NS. Role of microangiopathy in diabetic cardiomyopathy[J]. Heart Fail Rev,2014,19(1):25-33.
[27] Dimitropoulos J, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus[J]. World J Diabetes,2014,5(1):17-39.
[28] Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus[J]. Nat Rev Endocrinol,2012,8(7):405-416.
相似文献/References:
[1]赵靖华,综述,尚美生,等.衰老与心律失常[J].心血管病学进展,2016,(2):121.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.006]
ZHAO Jinghua,SHANG Meisheng,YAO Yan.Aging and Arrhythmias[J].Advances in Cardiovascular Diseases,2016,(4):121.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.006]
[2]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(4):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[3]郭晓曦,综述,张慧敏,等.慢性血栓栓塞性肺动脉高压[J].心血管病学进展,2016,(3):323.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.029]
GUO Xiaoxi,ZHANG Huimin.Chronic Thromboembolic Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(4):323.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.029]
[4]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[5]翟恒博,综述,刘俊,等.缺血性心脏病再认识[J].心血管病学进展,2016,(4):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
ZHAI Hengbo,LIU Jun.Rethinking of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(4):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
[6]杨沫,姜文锡.线粒体功能异常在糖尿病心肌病发病机制中的作用[J].心血管病学进展,2015,(6):731.[doi:10.3969/j.issn.1004-3934.2015.06.019]
YANG Mo,JIANG Wenxi.Mitochondrial Dysfunction of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2015,(4):731.[doi:10.3969/j.issn.1004-3934.2015.06.019]
[7]朱月红,戴启明.糖尿病心肌病的内质网病变机制及干预[J].心血管病学进展,2015,(6):738.[doi:10.3969/j.issn.1004-3934.2015.06.021]
ZHU Yuehong,DAI Qiming.Advance of Mechanism and Intervention of Endoplasmic Reticulum in
Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2015,(4):738.[doi:10.3969/j.issn.1004-3934.2015.06.021]
[8]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(4):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[9]秦莉 张艺文 杨晓倩 王燕凤 汪汉.系统性红斑狼疮合并心力衰竭的发病机制及病因[J].心血管病学进展,2020,(4):381.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.013]
QIN Li,ZHANG Yiwen,YANG Xiaoqian,et al.The Pathogenesis and Etiology of Heart Failure in Systemic lupus Erythematosus[J].Advances in Cardiovascular Diseases,2020,(4):381.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.013]
[10]武韧 常贵全 孙凤起 李鸿珠.硫化氢对糖尿病心肌病的保护作用[J].心血管病学进展,2021,(1):52.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
WU Ren,CHANG Guiquan,SUN Fengqi,et al.Protective Effect of Hydrogen Sulfide in Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(4):52.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]